FDA Roadmap by PHT

This FDA roadmap app presented by PHT Corporation is the first mobile app designed to help sponsors navigate the Roadmap to Patient-Focused Outcome Measurement in Clinical Trials released by the FDA in conjunction with their Clinical Outcome Assessment Qualification Program. The purpose of the roadmap is to help pharma improve clinical research that collects patient data through understanding the disease or condition, conceptualizing the treatment benefit resulting in identification of the targeted context of use (COU) and concept of interest (COI) for future clinical trial measurement.

PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research.